CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial Heart Failure and Atrial Fibrillation, Like Fire and Fury Primary Prevention of Heart Failure in Women Clinical applications of machine learning in the diagnosis, classification, and prediction of heart failure Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus

Clinical TrialNovember 10, 2018

JOURNAL:N Engl J Med. Article Link

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

SD Wiviott,I Raz,DECLARE–TIMI 58 Investigators. Keywords: Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Prevention, Acute Heart Failure, Hypertension, Smoking

FULL TEXT PDF